Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
BIIB

Market Cap: $32.08B

BI

Biogen Inc.

BIIB

NASDAQ (NASDAQ Global Select)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin67.71%

EBITDA Margin16.80%

EBIT Margin11.19%

Pre-tax Margin8.61%

Net Profit Margin8.39%

Earnings Yield2.60%

Valuation Multiples

Price / Book1.70

Price / Sales3.23

Price / Earnings38.23

PEG-0.83

Forward PEG1.15

EV / Sales3.94

EV / EBITDA23.43

EV / Operating Cash Flow13.60

EV / Free Cash Flow13.19

Price / Free Cash Flow10.81

Price / Operating Cash Flow11.14

Cash Flow & Capital

Free Cash Flow / Share$20.1

Operating Cash Flow / Share$19.49

Free Cash Flow Yield9.25%

Capex / Revenue0.90%

Capex / Operating Cash Flow3.12%

Capex / Depreciation0.22

Stock Compensation / Revenue1.36%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio1.87

Quick Ratio1.26

Cash Ratio0.33

Debt / Assets0.26

Debt / Capital0.31

Debt / Equity0.44

Long-Term Debt / Capital0.28

Debt / Market Cap25.22%

Net Debt / EBITDA4.23

Solvency Ratio0.11

Financial Leverage1.70

Efficiency & Working Capital

Asset Turnover0.31

Fixed Asset Turnover3.07

Inventory Turnover1.35

Receivables Turnover5.28

Payables Turnover7.95

Days Sales Outstanding69.18

Days Inventory Outstanding270.9

Days Payables Outstanding45.89

Operating Cycle340.09

Cash Conversion Cycle294.2

Working Capital Turnover2.08

Returns & Quality

Return on Equity4.52%

Return on Assets2.60%

Return on Invested Capital4.28%

ROCE4.52%

Return on Tangible Assets7.21%

Operating Return on Assets4.13%

Income Quality6.89

Tax Burden0.98

Interest Burden0.77

Balance Sheet & Intrinsic Metrics

Enterprise Value$39.15B

Invested Capital$27.14B

Working Capital$3.39B

Tangible Asset Value$-1.66B

Net Current Asset Value$-5.93B

Graham Number$127.41

Graham Net-Net-$63.29

Book Value / Share$127.61

Tangible Book Value / Share-$11.23

Cash / Share$8.7

Financial Health Scores

Piotroski Score4

Altman Z-Score2.91

Revenue$9.95B

EBIT$1.11B

Market Cap$31.9B

Working Capital$3.39B

Retained Earnings$20.97B

Total Assets$32.09B

Total Liabilities$13.24B